Amazing how this bad news is released after the ma
Post# of 148168
https://finance.yahoo.com/news/sanofi-regener...00748.html
Sarilumab doesn't hit primary or secondary endpoints; trial stopped.
Read More: https://investorshangout.com/post/newpost/605...z6R5YWDujH